
aMoon
About
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
Key facts
At-a-glance profile data
- Website
- amoon.fund
- Type
- Venture Capital
- Headquarters
- Israel
- Funds raised
- $1.3B
- Portfolio companies
- 22
- Stages
- SeedSeries ASeries BSeries C
- Cheque size
- $10M to $50M
- Sector focus
- Life SciencesCancerTherapeuticsBiotechPersonalized Treatment
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 28 Jan 2025 | Lutris Pharma | Series A | $30M |
| 1 Oct 2024 | Air Doctor | Series B | $20M |
| 1 Jun 2024 | Cavos Biotech | Seed | Undisclosed |
| 8 Nov 2023 | Eleos Health | Series B | $40M |
| 6 Sept 2023 | Ibex Medical Analytics | Series C | $55M |
| 30 Nov 2022 | Nectin Therapeutics | Series B | $25M |
| 5 Apr 2022 | Eleos Health | Series A | $20M |
| 13 Sept 2021 | Eleos Health | Seed | $6M |
| 31 May 2021 | DayTwo | Series C | $37M |
| 9 Mar 2021 | Ibex Medical Analytics | Series B | $38M |
Frequently asked
What companies has aMoon invested in?
aMoon has invested in Lutris Pharma, Air Doctor, Cavos Biotech, Eleos Health, Ibex Medical Analytics and 17 more.
